Back
United Therapeutics Stock Price Chart
Sponsored
UTHR
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
UTHR
United Therapeutics
Last Price:
351.26
Seasonality Move:
2.3%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.
United Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 343.77 | Sell |
20-day SMA: | 348.9 | Sell |
50-day SMA: | 337.32 | Buy |
200-day SMA: | 269.62 | Buy |
8-day EMA: | 344.43 | Sell |
20-day EMA: | 344.47 | Sell |
50-day EMA: | 334.05 | Buy |
200-day EMA: | 285.84 | Buy |
United Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.02 | Buy |
Relative Strength Index (14 RSI): | 49.83 | Sell |
Chaikin Money Flow: | -210533 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (335.44 - 355.88) | Sell |
Bollinger Bands (100): | (276.58 - 343.14) | Buy |
United Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 342.59 while UTHR 8-day simple moving average is 343.77, which is a Sell signal.
- The stock price of UTHR is 342.59 while United Therapeutics 20-day SMA is 348.90, which makes it a Sell.
- United Therapeutics 50-day simple moving average is 337.32 while UTHR share price is 342.59, making it a Buy technically.
- UTHR stock price is 342.59 and United Therapeutics 200-day simple moving average is 269.62, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Sell
49
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a Sell
The current United Therapeutics [UTHR] share price is $342.59. The Score for UTHR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
United Therapeutics Stock Info
Market Cap:
15.24B
Price in USD:
342.59
Share Volume:
263.85K
United Therapeutics 52-Week Range
52-Week High:
366.08
52-Week Low:
208.62
Sell
49
United Therapeutics (UTHR)
is a Sell
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?
The United Therapeutics stock price is 342.59 USD today. -
Will UTHR stock go up or go down?
United Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is United Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is overvalued.
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 342.59 while UTHR 8-day exponential moving average is 344.43, which is a Sell signal.
- The stock price of UTHR is 342.59 while United Therapeutics 20-day EMA is 344.47, which makes it a Sell.
- United Therapeutics 50-day exponential moving average is 334.05 while UTHR share price is 342.59, making it a Buy technically.
- UTHR stock price is 342.59 and United Therapeutics 200-day simple moving average is 285.84, creating a Buy signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.87 per share, and an increase next year of $1.42 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
- UTHR Moving Average Covergence Divergence (MACD) indicator is 2.02, suggesting United Therapeutics is a Buy
- United Therapeutics Relative Strength Index (RSI) is 49.83, which suggest United Therapeutics is oversold
- The Bollinger Bands (25) for United Therapeutics is (335.44 - 355.88), which suggest United Therapeutics is a Buy
- The Bollinger Bands (100) for United Therapeutics is (276.58 - 343.14), which suggest United Therapeutics is a Buy
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.